Remember meForgot password?
    Log in with Twitter

drug development News

Essential Science: Round-up of COVID-19 drug developments

For this week's Essential science column, we delve into the latest research on the quest to develop drugs to help combat COVID-19 symptoms or to eliminate the novel SARS-CoV-2 coronavirus itself.

Essential Science: How AI is advancing medical science

Artificial intelligence is becoming more commonplace in medicine, helping to advance drug development and with aiding specialists with deciphering medical images. This week’s ‘Essential Science’ looks at key developments.

Q&A: Tackling underrepresentation in clinical trials Special

Today’s clinical trial and research space faces a number of challenges, including limitations in data quality and trials that effectively address underserved populations, impacting the efficacy of drug benefits and treatments of complex diseases.

Essential Science: Machine learning predicts metabolism

London - Researchers are testing out machine learning algorithms which can make a prediction about yeast metabolism based on an assessment of the yeast protein content. This insight will aid scientists to personalize treatments for metabolic disorder patients.

Using AI to speed drug discovery

Toronto - A new healthcare startup venture, formed from University of Toronto researchers, has raised sufficient capital to begin developing a program to assess existing research in order to speed up new medicinal drug discovery.

Blockchain technology to equip scientists and drug developers Special

Caywon Pharmaceuticals Group has adopted blockchain technology to equip scientists with the necessary IT tools to translate their requirements into a digital workflow by using Crowd Machine. Dr. Matthew Lee, VP of Innovations at Caywon explains more.

GSK and Exscientia to collaborate on artificial intelligence

London - Technology company Exscientia and major pharmaceuticals manufacturer GlaxoSmithKline are coming together to develop artificial intelligence for the discovery of new small molecule therapies.

Typical drug development costs $2.6 billion

How much does it cost to produce a pharmaceutical product these days? According to a new study, the typical cost has rocketed to $2.6 billion. The $ figure is up from an estimated price tag of $1 billion from an analysis published in 2003.

Search Digital Journal Archives

Set up a news alert for

drug development

drug development Image

Latest News
Top News